Go offline with the Player FM app!
#180 Beta-Blockers & REDUCE-AMI Trial: Beyond Journal Club Segment with NEJM Group
Manage episode 490704970 series 2466684
How much do beta blockers help after a heart attack, even when the heart’s pumping well? In this episode, we revisit the origins of beta blockers in post-MI care, examine how evidence evolved, and explore the REDUCE-AMI trial, which questions whether beta blockers are still needed for all.
Listen to this latest episode of Beyond Journal Club, a collaboration between Core IM and NEJM Group, where we put research into context tracing the arc of evidence, dissecting the clinical question, and exploring what the findings could mean for real-world patient care
🔹 Sponsor: NEJM Fellowship Program, click here to learn more and/or apply!
Timestamps:
(00:48) | Background on Beta Blockers and Their Mechanism
(02:41) | Historical Context of Beta Blockers in Heart Disease
(04:56) | Capricorn Trial and Its Impact
(07:17) | Emergence of Doubts About Beta Blockers
(10:09) | Introduction to the REDUCED-AMI Trial
(15:52) | Discussion on Trial Interpretation and Clinical Implications
(16:18) | Comparison with Other Trials and Future Directions
Tags: CoreIM, Internal Medicine, Primary Care, Medical Education, IMCore, Physician Assistant, Nurse Practitioner, Medical Student, Cardiology
Find the best disability insurance for you: https://www.patternlife.com/disability-insurance?campid=497840
Our Sponsors:
* Check out Eko Core 500 Digital Stethoscope: https://ekohealth.com/COREIM
* Check out FIGS and use code FIGSRX for 15% off your 1st order: https://wearfigs.com
Advertising Inquiries: https://redcircle.com/brands
Privacy & Opt-Out: https://redcircle.com/privacy
200 episodes
Manage episode 490704970 series 2466684
How much do beta blockers help after a heart attack, even when the heart’s pumping well? In this episode, we revisit the origins of beta blockers in post-MI care, examine how evidence evolved, and explore the REDUCE-AMI trial, which questions whether beta blockers are still needed for all.
Listen to this latest episode of Beyond Journal Club, a collaboration between Core IM and NEJM Group, where we put research into context tracing the arc of evidence, dissecting the clinical question, and exploring what the findings could mean for real-world patient care
🔹 Sponsor: NEJM Fellowship Program, click here to learn more and/or apply!
Timestamps:
(00:48) | Background on Beta Blockers and Their Mechanism
(02:41) | Historical Context of Beta Blockers in Heart Disease
(04:56) | Capricorn Trial and Its Impact
(07:17) | Emergence of Doubts About Beta Blockers
(10:09) | Introduction to the REDUCED-AMI Trial
(15:52) | Discussion on Trial Interpretation and Clinical Implications
(16:18) | Comparison with Other Trials and Future Directions
Tags: CoreIM, Internal Medicine, Primary Care, Medical Education, IMCore, Physician Assistant, Nurse Practitioner, Medical Student, Cardiology
Find the best disability insurance for you: https://www.patternlife.com/disability-insurance?campid=497840
Our Sponsors:
* Check out Eko Core 500 Digital Stethoscope: https://ekohealth.com/COREIM
* Check out FIGS and use code FIGSRX for 15% off your 1st order: https://wearfigs.com
Advertising Inquiries: https://redcircle.com/brands
Privacy & Opt-Out: https://redcircle.com/privacy
200 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.